The Illinois Department of Public Health (IDPH) is adopting the Centers for Disease Control and Prevention (CDC) recommendation for those aged 12-15 years to get a booster dose five months after receiving the second dose of Pfizer-BioNTech COVID-19 vaccine. CDC now recommends that adolescents aged 12 to 17 years old should receive a booster shot five months after their initial Pfizer-BioNTech vaccination series.Only Pfizer-BioNTech COVID-19 vaccine is currently authorized in this age group.

The CDC Media Release, including a statement from CDC Director Rochelle Walensky, can be found here. The Pfizer-BioNTech COVID-19 Vaccine Provider and Recipient/Caregiver Fact Sheets have been updated following the FDA’s amendments on 01/03/2022. The EUA fact sheets can be found here. The Food and Drug Administration media statement can be found here.

“We know that COVID-19 vaccine booster doses can help provide ongoing protection against the Omicron variant,” said IDPH Director Dr. Ngozi Ezike.  “Following the CDC’s recommendation, booster doses are encouraged for those aged 12-15 years who received their second dose of Pfizer-BioNTech vaccine five months ago.”

On January 3, 2022, the Food and Drug Administration (FDA) amended the emergency use authorization for the Pfizer-BioNTech vaccine and expanded it to include a single booster doses for individuals 12-15 years. The Advisory Committee on Immunization Practices reviewed the available safety data following the administration of more than 25 million vaccine doses in adolescents and concluded COVID-19 vaccines are safe and effective.

At this time, only the Pfizer-BioNTech COVID-19 vaccine is authorized and recommended for adolescents aged 12-15.